Paltimatrectinib
Modify Date: 2024-01-10 18:51:45
Paltimatrectinib structure
|
Common Name | Paltimatrectinib | ||
|---|---|---|---|---|
| CAS Number | 2353522-15-1 | Molecular Weight | 434.37 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H15F5N6 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of PaltimatrectinibPaltimatrectinib (compound I-147) is a potent tyrosine kinase inhibitor with an IC50 of <10 nM for tropomyosin kinases A (TrkA). Paltimatrectinib has the potential for cancer and inflammatory diseases[1]. |
| Name | Paltimatrectinib |
|---|
| Description | Paltimatrectinib (compound I-147) is a potent tyrosine kinase inhibitor with an IC50 of <10 nM for tropomyosin kinases A (TrkA). Paltimatrectinib has the potential for cancer and inflammatory diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
TrkA |
| References |
| Molecular Formula | C20H15F5N6 |
|---|---|
| Molecular Weight | 434.37 |